Search Results - "Willsher, P."

Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study) by Chan, Arlene, De Boer, R., Gan, A., Willsher, P., Martin, R., Zissiadis, Y., Miller, K., Bauwens, A., Hastrich, D.

“…Purpose Aromatase inhibitors are standard of care in women with hormone receptor-positive early breast cancer. Published evidence demonstrates that adverse…”
Get full text

Microbubble detection and ultrasound-guided vacuum-assisted biopsy of axillary lymph nodes in patients with breast cancer by Britton, P, Willsher, P, Taylor, K, Kilburn-Toppin, F, Provenzano, E, Forouhi, P, Benson, J, Agrawal, A, Forman, J.R, Wallis, M.G

“…Aims To assess the feasibility of undertaking microbubble-guided vacuum-assisted biopsy (VAB) of the sentinel lymph node (SLN) and determine its sensitivity in…”
Get full text

Randomized clinical trial of single-dose antibiotic prophylaxis for non-reconstructive breast surgery by Hall, J. C., Willsher, P. C., Hall, J. L.

“…Background: The aim of this randomized clinical trial was to determine whether a single intravenous dose of 2 g flucloxacillin could prevent wound infection…”
Get full text

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer by Robertson, J.F.R, Willsher, P.C, Winterbottom, L, Blamey, R.W, Thorpe, S

“…The progesterone receptor antagonist, Onapristone, is an effective endocrine agent in experimental breast cancer models. This study aimed to investigate this…”
Get full text

Transperitoneal laparoscopic exposure for lumbar interbody fusion by Lieberman, I H, Willsher, P C, Litwin, D E, Salo, P T, Kraetschmer, B G

“…A prospective clinical trial of the transperitoneal laparoscopic approach to the lumbar spine in a consecutive series of patients undergoing anterior lumbar…”
Get full text

The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer by Robertson, J.F.R., Willsher, P.C., Cheung, K.L., Blarney, R.W.

“…This study reports on the clinical relevance of the static disease (SD) category in 255 breast cancer patients on endocrine therapy. All patients had received…”
Get full text

Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy by Tan, S.M, Cheung, K.L, Willsher, P.C, Blamey, R.W, Chan, S.Y, Robertson, J.F.R

“…We report the medium-term (median follow-up=52 months) results of a prospective randomised trial of multimodal therapy (neoadjuvant chemotherapy, Patey…”
Get full text

Prognostic significance of serum c-erbB-2 protein in breast cancer patients by WILLSHER, P. C, BEAVER, J, PINDER, S, BELL, J. A, ELLIS, I. O, BLAMEY, R. W, ROBERTSON, J. F. R

“…The tissue expression of c-erbB-2 protein in breast cancer is a marker of poor prognosis in a number of studies. More recently it has also been suggested that…”
Get full text

A comparison outcome of male breast cancer with female breast cancer by Willsher, Peter C., Leach, Iain H., Ellis, Ian O., Bourke, Jim B., Blamey, Roger W., Robertson, John F.R.

“…It is unclear whether breast cancer has a similar prognosis in males and females. A 20-year retrospective study of all male breast cancer patients in our…”
Get full text

Male breast cancer: pathological and immunohistochemical features by Willsher, P C, Leach, I H, Ellis, I O, Bell, J A, Elston, C W, Bourke, J B, Blamey, R W, Robertson, J F

“…male breast cancer is uncommon and studies regarding the potential clinical relevance of the histopathological and immunohistochemical features are…”
Get more information

Abstract P6-19-04: Male breast cancer: Tumour characteristics and treatment compared with females in Australia – 99,768 breast cancers over a 10 year period by Arlene, C, Chris, L, Chih, H, Willsher, P

“…Abstract Introduction Stage and tumour characteristics in males with early breast cancer (EBC) differ from those in females. Guidelines recommend that…”
Get full text

Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer by KENNY, Frances S, WILLSHER, Peter C, GEE, Julia M. W, NICHOLSON, Robert I, PINDER, Sarah E, ELLIS, Ian O, ROBERTSON, John F. R

“…Pre-treatment oestrogen receptor (ER) expression in breast cancer predicts for rate of response to endocrine therapy but not for the quality or duration of…”
Get full text

Locally advanced breast cancer: early results of a randomised trial of multimodal therapy versus initial hormone therapy by Willsher, P.C., Robertson, J.F.R., Chan, S.Y., Jackson, L., Blarney, R.W.

“…The aim of this study was to investigate initial treatment of locally advanced breast cancer. Patients were randomised to “multimodal” therapy (pre-operative…”
Get full text

P136 Preoperative TAC (docetaxel, doxorubicin, cyclophosphamide) in conjunction with the development of a standard protocol for the management of locally advanced breast cancer by Chan, A, Willsher, P, Joseph, D, Hastrich, D, Ingram, D, Latham, B, Redfern, A, Anderson, J, Thomson, J, van der Schaaf, A

Get full text

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer by Willsher, P C, Pinder, S E, Gee, J M, Ellis, I O, Chan, S Y, Nicholson, R I, Blamey, R W, Robertson, J F

“…Previous work suggests that the presence of c-erbB2 oncoprotein immunostaining and the proliferation rate of tumours, may be relevant to chemo-sensitivity in…”
Get more information

Predictors of response to second-line endocrine therapy for breast cancer by CHEUNG, K. L, WILLSHER, P. C, PINDER, S. E, ELLIS, I. O, ELSTON, C. W, NICHOLSON, R. I, BLAMEY, R. W, ROBERTSON, J. F. R

“…This study reports on factors predicting response to second-line endocrine therapy in 250 patients with breast cancer for which they were assessable for…”
Get full text

Endocrine response and resistance in breast cancer: a role for the transcription factor Fos by Gee, Julia M.W., Willsher, Peter C., Kenny, Frances S., Robertson, John F.R., Pinder, Sarah E., Ellis, Ian O., Nicholson, Robert I.

“…We have previously demonstrated that elevated Fos expression may be important in de novo endocrine resistance in breast cancer. However, changes in Fos…”
Get full text

Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer by Al-Hilaly, M., Willsher, P.C., Robertson, J.F.R., Blamey, R.W.

“…Between April 1982 and February 1994, 344 women aged >70 years with cancers <5 cm in diameter were treated at the City Hospital Breast Unit. The majority were…”
Get full text

The significance of p53 autoantibodies in the serum of patients with breast cancer by Willsher, P C, Pinder, S E, Robertson, L, Nicholson, R I, Ellis, I O, Bell, J A, Blamey, R W, Green, J A, Robertson, J F

“…Serum p53 autoantibodies were studied in 82 patients with Stage 1 or 2 breast cancer using an ELISA assay. Tissue expression of p53 in these patients was also…”
Get more information

Early laparoscopic cholecystectomy for acute cholecystitis: a safe procedure by Willsher, Peter C., Sanabria, Juan-Ramon, Gallinger, Steven, Rossi, Ljubo, Strasberg, Steven, Litwin, Demetrius E.M.

“…Acute cholecystitis is increasingly managed by laparoscopic cholecystectomy. Some reports have shown conversion and complication rates that are increased in…”
Get full text